These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [The use of a complex preparation of alpha-interferon and first-phase immune-response cytokines--leukinferon]. Gruzdeva TA; Kuznetsov VP; Beliaev DL; Vakhman IS; Fedorova NV; Babaiants AA; Polikarpova EV Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):59-64. PubMed ID: 8184616 [TBL] [Abstract][Full Text] [Related]
25. [The effect of treatment on the course of invasion by Hymenolepis nana and the state of its population in white mice]. Malysheva NS Med Parazitol (Mosk); 1998; (2):46-8. PubMed ID: 9691622 [TBL] [Abstract][Full Text] [Related]
26. [The clinico-immunological effects of leukinferon in the treatment of patients with acute suppurative pyelonephritis]. Vozianov AF; Kuznetsov VP; Driianskaia VE; Pasechnikov SP; Ozvinchuk II; Fedoruk GV; Drannik GN Lik Sprava; 1997; (1):88-92. PubMed ID: 9221157 [TBL] [Abstract][Full Text] [Related]
27. [The clinical efficacy in using leukinferon in adults with diseases caused by the varicella-zoster virus]. Kuznetsov VP; Nikolaeva IN; Barer GM; Beliaev DL; Sundukov AV; Babaiants AA; Iushchuk ND Zh Mikrobiol Epidemiol Immunobiol; 1995; (4):72-5. PubMed ID: 9381878 [TBL] [Abstract][Full Text] [Related]
28. [Combined detoxification and immunocorrective therapy in patients with peritonitis]. Shkrob LO; Fedotov PA; Ermakova NG Khirurgiia (Mosk); 1994 Mar; (3):20-2. PubMed ID: 8007606 [TBL] [Abstract][Full Text] [Related]
30. [Use of cytokines in the complex treatment of respiratory diseases]. Gel'tser BI; Prosekova EV; Kondrashova NM Klin Med (Mosk); 2004; 82(9):13-9. PubMed ID: 15540415 [No Abstract] [Full Text] [Related]
31. The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis. Khomenko AG; Insanov AB Z Erkr Atmungsorgane; 1986; 167(1-2):163-7. PubMed ID: 3765712 [TBL] [Abstract][Full Text] [Related]
32. [Efficiency of immunocorrection using cytokines in the therapy of papillomavirus infection]. Dubenskiĭ VV; Kuznetsov VP; Beliaev DL; Sliusar' NN Zh Mikrobiol Epidemiol Immunobiol; 2001; (5):54-8. PubMed ID: 11871303 [TBL] [Abstract][Full Text] [Related]
33. [Leukinferon in the treatment of patients with sepsis and multiple organ dysfunction syndrome]. Kuznetsov VP; Markelova EV; Smirnov GA; Lazanovich VA; Beliaev DL Antibiot Khimioter; 2002; 47(5):3-7. PubMed ID: 12365325 [TBL] [Abstract][Full Text] [Related]
34. [Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis]. Averchenkov VM; Lomachenkov VD; Fedotova NI; Meshkova RIa Probl Tuberk; 1998; (2):20-2. PubMed ID: 9613178 [TBL] [Abstract][Full Text] [Related]
35. [Effects of interferon preparations on the course of Salmonella infection (experimental and clinical studies)]. Spivak NIa; Fil'chakov IV; Treshchinskiĭ AI; Kuznetsov VP; Zaritskiĭ AM; Belotskiĭ SM Antibiot Khimioter; 1992 Mar; 37(3):28-31. PubMed ID: 1514865 [TBL] [Abstract][Full Text] [Related]
36. [The effect of indomethacin and leukinferon on the thromboxane B2 level in the blood plasma of patients with endometrial cancer in the perioperative period]. Bassalyk LS; Shoshiashvili VD; Kushlinskiĭ NE; Mistakopulo NF; Kuznetsov VP; Rylov VV; Liakina LT Vopr Onkol; 1992; 38(5):555-61. PubMed ID: 1300754 [TBL] [Abstract][Full Text] [Related]
37. [The interferon reaction of the leukocytes and the natural killer activity in patients with acute viral hepatitis B undergoing interferon treatment]. Golban TD; Cheshik SG; Kuznetsov VP; Beliaev DL; Grishchenko SV; Morgunov KM; Babaiants AA; Polikushina OE; Antonenko SM Vopr Virusol; 1994; 39(4):177-9. PubMed ID: 7998397 [TBL] [Abstract][Full Text] [Related]
38. [Levamisole and diucifon immunochemotherapy of chronic destructive pulmonary tuberculosis]. Khomenko AG; Insanov AB Probl Tuberk; 1984 Sep; (9):23-7. PubMed ID: 6504881 [No Abstract] [Full Text] [Related]
39. [The use of leukinferon in treating zoonotic cutaneous leishmaniasis. 2. Patient treatment]. Sergiev VP; Shuĭkina EE; Kuznetsov VP; Beliaev DL; Fediainova IE; Norbadalov MT; Suntsov SN Med Parazitol (Mosk); 1993; (1):42-3. PubMed ID: 8336652 [TBL] [Abstract][Full Text] [Related]
40. [The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis]. Medus AI; Pisarevskaia LI; Nikishina EV Voen Med Zh; 1999 Oct; 320(10):65-7, 96. PubMed ID: 10605346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]